button bars forest bayes pooled summary circles
 
deaths (OS)

la/mBC - HER2 positive - 1st Line (L1) breast cancer - HER2-positive la/mBC - HER2 positive la/mBC - HER2 positive - 1st Line (L1)

versus trastuzumab plus docetaxel
bevacizumab plus trastuzumab plus docetaxel vs. trastuzumab plus docetaxel 1 0.94 [0.68; 1.30], 1 RCT, I2=0%
inconclusive result

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons